In a safety communication issued on 30 November, the US Food and Drug Administration said it is evaluating data from Chinese-manufactured plastic syringes for potential device failure. The syringes in question inject fluids — or withdraws fluid — from the body. The FDA noted, however, that glass syringes, pre-filled syringes, or those used for oral or topical purposes are not under scrutiny at this time.
FDA Evaluating Safety Of Plastic Syringes From China, May Prevent Their Import To The US
The US FDA is advising the public that certain plastic syringes from China could fail, leak, or break. If necessary, the agency may prevent Chinese syringes from entering the US.
More from Regulation
More from Policy & Regulation
• By
Calley Means defended reductions in force at the Health and Human Services Department that shocked and outraged federal workers and stakeholders.
• By
Some employees were not impressed with FDA Commissioner Martin Makary's first speech to the agency staff, saying he did not seem to understand the agency's mission.
• By
Swiss medtech exporters seek urgent diplomatic action from the Swiss Federal Council in a bid to overturn the 2 April US decision to put tariffs on goods imports.